CD80 Rabbit Polyclonal Antibody

CD80 Rabbit Polyclonal Antibody

 

CD80 Rabbit pAb

A16039-200ul Abclonal 200 ul 550.8 EUR

CD80 Rabbit pAb

A16039-20ul Abclonal 20 ul 219.6 EUR

CD80 Rabbit pAb

A16039-50ul Abclonal 50 ul 267.6 EUR

CD80 Rabbit mAb

A19025-100ul Abclonal 100 ul 492 EUR

CD80 Rabbit mAb

A19025-200ul Abclonal 200 ul 685.2 EUR

CD80 Rabbit mAb

A19025-20ul Abclonal 20 ul 265.2 EUR

CD80 Rabbit mAb

A19025-50ul Abclonal 50 ul 344.4 EUR

Polyclonal CD80 Antibody (internal region)

APR11032G Leading Biology 0.1 mg 580.8 EUR
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human CD80 (internal region). This antibody is tested and proven to work in the following applications:

CD80 antibody

70R-35657 Fitzgerald 100 ug 418.8 EUR
Description: Rabbit polyclonal CD80 antibody

CD80 antibody

70R-13908 Fitzgerald 100 ug 386.4 EUR
Description: Affinity purified Mouse polyclonal CD80 antibody

CD80 Antibody

49409-100ul SAB 100ul 399.6 EUR

CD80 Antibody

49409-50ul SAB 50ul 286.8 EUR

CD80 Antibody

37436-100ul SAB 100ul 302.4 EUR

CD80 antibody

10R-6436 Fitzgerald 100 ug 282 EUR
Description: Armenian Hamster monoclonal CD80 antibody

CD80 antibody

10R-6437 Fitzgerald 100 ug 230.4 EUR
Description: Mouse monoclonal CD80 antibody

CD80 antibody

10R-6844 Fitzgerald 100 ul 829.2 EUR
Description: Mouse monoclonal CD80 antibody

CD80 antibody

10R-7741 Fitzgerald 500 ug 678 EUR
Description: Rat monoclonal CD80 antibody

CD80 antibody

10R-CD80bMS Fitzgerald 500 ug 444 EUR
Description: Rat monoclonal CD80 antibody

CD80 antibody

10R-1912 Fitzgerald 100 ul 483.6 EUR
Description: Mouse monoclonal CD80 antibody

CD80 antibody

10R-3627 Fitzgerald 100 ul 829.2 EUR
Description: Mouse monoclonal CD80 antibody

CD80 antibody

10R-3628 Fitzgerald 100 ul 829.2 EUR
Description: Mouse monoclonal CD80 antibody

CD80 antibody

10R-3629 Fitzgerald 100 ul 829.2 EUR
Description: Mouse monoclonal CD80 antibody

CD80 antibody

10R-3630 Fitzgerald 100 ul 829.2 EUR
Description: Mouse monoclonal CD80 antibody

CD80 antibody

10R-3631 Fitzgerald 100 ul 829.2 EUR
Description: Mouse monoclonal CD80 antibody

CD80 antibody

10R-3632 Fitzgerald 100 ul 829.2 EUR
Description: Mouse monoclonal CD80 antibody

CD80 antibody

10R-3634 Fitzgerald 100 ul 829.2 EUR
Description: Mouse monoclonal CD80 antibody

CD80 antibody

10R-3635 Fitzgerald 100 ul 829.2 EUR
Description: Mouse monoclonal CD80 antibody

CD80 Antibody

ABD7682 Lifescience Market 100 ug 525.6 EUR

CD80 Antibody

ABD8145 Lifescience Market 100 ug 525.6 EUR

CD80 Antibody

8679-002mg ProSci 0.02 mg 206.18 EUR
Description: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody

8679-01mg ProSci 0.1 mg 523.7 EUR
Description: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody

DF7682 Affbiotech 200ul 420 EUR

CD80 Antibody

1-CSB-PA129040 Cusabio
  • 266.40 EUR
  • 234.00 EUR
  • 100ug
  • 50ug
Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC-p:1:50-300, ELISA:1:10000-20000

CD80 Antibody

1-CSB-PA130815 Cusabio
  • 380.40 EUR
  • 292.80 EUR
  • 100ul
  • 50ul
Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100

CD80 Antibody

1-CSB-PA277650 Cusabio
  • 380.40 EUR
  • 292.80 EUR
  • 100ul
  • 50ul
Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200

CD80 Antibody

1-CSB-PA004959GA01HU Cusabio
  • 716.40 EUR
  • 399.60 EUR
  • 150ul
  • 50ul
Description: A polyclonal antibody against CD80. Recognizes CD80 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB

CD80 antibody

PAab09813 Lifescience Market 100 ug 463.2 EUR

CD80 Antibody

R30433 NSJ Bioreagents 100 ug 419 EUR

CD80 Antibody

R30434 NSJ Bioreagents 100 ug 419 EUR

CD80 Antibody

R34234-100UG NSJ Bioreagents 100 ug 399 EUR

CD80 Antibody

RQ4248 NSJ Bioreagents 100 ug 419 EUR

CD80 Antibody

F48980-0.08ML NSJ Bioreagents 0.08 ml 165 EUR

CD80 Antibody

F48980-0.4ML NSJ Bioreagents 0.4 ml 379 EUR

CD80 Antibody

RQ6838 NSJ Bioreagents 100ug 419 EUR
Description: Cluster of Differentiation 80 (also CD80 and B7-1) is a protein found on activated B cells and monocytes that provides a costimulatory signal necessary for T cell activation and survival. It is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD80 works in tandem with CD86 to prime T cells. The CD80 genes encode B7-1 which are structurally similar members of the immunoglobulin superfamily expressed on a variety of hematopoietic cell types.

CD80 Antibody

V3297-100UG NSJ Bioreagents 100 ug 499 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V3297-20UG NSJ Bioreagents 20 ug 219 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V3297SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V7382-100UG NSJ Bioreagents 100 ug 499 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V7382-20UG NSJ Bioreagents 20 ug 219 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V7382IHC-7ML NSJ Bioreagents 7 ml 499 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V7382SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V7498-100UG NSJ Bioreagents 100 ug 499 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V7498-20UG NSJ Bioreagents 20 ug 219 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V7498SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V8234-100UG NSJ Bioreagents 100 ug 499 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V8234-20UG NSJ Bioreagents 20 ug 219 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V8234SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V8522-100UG NSJ Bioreagents 100 ug 499 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V8522-20UG NSJ Bioreagents 20 ug 219 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

CD80 Antibody

V8522SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: T cell proliferation and lymphokine production are triggered by occupation of the TCR by antigen, followed by a costimulatory signal that is delivered by a ligand expressed on antigen presenting cells. The B7-related cell surface proteins CD80 (B7-1) and CD86 (B7-2) are expressed on antigen presenting cells bind the homologous T cell receptors CTLA-4 (cytotoxic T lymphocyte-associated protein-4) and CD28 and trigger costimulatory signals for optimal T cell activation. CTLA-4 shares 31% overall amino acid identity with CD28 and it has been proposed that CD28 and CTLA-4 are functionally redundant. SLAM is a novel receptor on T cells that, when engaged, potentiates T cell expansion in a CD28-independent manner. B7, also designated BB1, is another ligand or counter receptor for CD28 and CTLA-4 that is expressed on the antigen-presenting cell.

Rabbit T- lymphocyte activation antigen CD80, CD80 ELISA KIT

ELI-06510Ra Lifescience Market 96 Tests 1113.6 EUR

Anti-CD80/B7 1 Rabbit Monoclonal Antibody

M00196 BosterBio 100ug/vial 476.4 EUR
Description: Rabbit Monoclonal CD80/B7 1 Antibody. Validated in IHC, WB and tested in Human.

Polyclonal CD80 antibody - C-terminal region

APR11033G Leading Biology 0.05mg 633.6 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CD80 - C-terminal region. This antibody is tested and proven to work in the following applications:

CD80

80A-100T ImmunoStep 100 test 450 EUR

CD80

80F-100T ImmunoStep 100 test 372 EUR

CD80

80PE-100T ImmunoStep 100 test 762 EUR

CD80

MO80A(V100) ImmunoStep 100 ug 60 EUR

CD80

MO80A(V25) ImmunoStep 25 ug 60 EUR

CD80

MO80B(V100) ImmunoStep 100 ug 60 EUR

CD80

MO80B(V25) ImmunoStep 25 ug 60 EUR

CD80

MO80CFB(V100) ImmunoStep 100 ug 60 EUR

CD80

MO80CFB(V25) ImmunoStep 25 ug 60 EUR

CD80

MO80F(V100) ImmunoStep 100 ug 60 EUR

CD80

MO80F(V25) ImmunoStep 25 ug 60 EUR

CD80

MO80F(V500) ImmunoStep 500 ug 60 EUR

CD80

MO80PE(V100) ImmunoStep 100 ug 60 EUR

CD80

MO80PE(V25) ImmunoStep 25 ug 60 EUR

CD80

MO80PP(V100) ImmunoStep 100 ug 60 EUR

CD80

MO80PP(V25) ImmunoStep 25 ug 60 EUR

CD80

MO80PP5.5(V100) ImmunoStep 100 ug 60 EUR

CD80

MO80PP5.5(V25) ImmunoStep 25 ug 60 EUR

CD80

MO80PU(V100) ImmunoStep 100 ug 60 EUR

CD80

MO80PU(V500) ImmunoStep 500 ug 60 EUR

T-lymphocyte activation antigen CD80 (CD80) Antibody

20-abx019054 Abbexa
  • 410.40 EUR
  • 109.20 EUR
  • 100 ug
  • 10 ug

CD80 antibody (FITC)

61R-1108 Fitzgerald 100 ug 360 EUR
Description: Armenian Hamster monoclonal CD80 antibody (FITC)

CD80 antibody (PE)

61R-1274 Fitzgerald 100 ug 379.2 EUR
Description: Mouse monoclonal CD80 antibody (PE)

CD80 antibody (PE)

61R-1275 Fitzgerald 100 ug 424.8 EUR
Description: Armenian Hamster monoclonal CD80 antibody (PE)

CD80 antibody (PE)

61R-1276 Fitzgerald 100 tests 463.2 EUR
Description: Mouse monoclonal CD80 antibody (PE)

CD80 antibody (biotin)

61R-1527 Fitzgerald 100 ug 379.2 EUR
Description: Mouse monoclonal CD80 antibody (biotin)

CD80 antibody (biotin)

61R-1528 Fitzgerald 100 ug 340.8 EUR
Description: Armenian Hamster monoclonal CD80 antibody (biotin)

CD80 antibody (biotin)

61R-1529 Fitzgerald 100 ug 379.2 EUR
Description: Mouse monoclonal CD80 antibody (biotin)

CD80 antibody (allophycocyanin)

61R-1743 Fitzgerald 100 ug 548.4 EUR
Description: Armenian Hamster monoclonal CD80 antibody (allophycocyanin)

CD80 antibody (FITC)

61R-CD80bHUFT Fitzgerald 120 tests 651.6 EUR
Description: Mouse monoclonal CD80 antibody (FITC)

CD80 antibody (Allophycocyanin)

61R-CD80bMSAPC Fitzgerald 100 ug 522 EUR
Description: Rat monoclonal CD80 antibody (Allophycocyanin)

CD80 antibody (biotin)

61R-CD80bMSBT Fitzgerald 500 ug 495.6 EUR
Description: Rat monoclonal CD80 antibody (biotin)

CD80 antibody (FITC)

61R-CD80bMSFT Fitzgerald 500 ug 548.4 EUR
Description: Rat monoclonal CD80 antibody (FITC)

CD80 antibody (PE)

61R-CD80bMSPE Fitzgerald 200 ug 548.4 EUR
Description: Rat monoclonal CD80 antibody (PE)

Hamster CD80 Antibody

abx140014-01mg Abbexa 0.1 mg 343.2 EUR

Anti-CD80 Antibody

A00196-1 BosterBio 100ug/vial 400.8 EUR

CD80 Conjugated Antibody

C49409 SAB 100ul 476.4 EUR

Anti-CD80 antibody

PAab01500 Lifescience Market 100 ug 463.2 EUR

anti- CD80 antibody

FNab01500 FN Test 100µg 658.5 EUR
Description: Antibody raised against CD80

anti- CD80 antibody

FNab09813 FN Test 100µg 658.5 EUR
Description: Antibody raised against CD80

Anti-CD80 Antibody

PA1365 BosterBio 100ug/vial 352.8 EUR

Anti-CD80 Antibody

PA1365-1 BosterBio 100ug/vial 352.8 EUR

Anti-CD80 antibody

STJ118492 St John's Laboratory 100 µl 332.4 EUR

Anti-CD80 antibody

STJ98977 St John's Laboratory 200 µl 236.4 EUR
Description: Rabbit polyclonal to CD80.

Anti-CD80 antibody

STJ97938 St John's Laboratory 100 µl 280.8 EUR
Description: Mouse monoclonal to CD80.

Anti-CD80 Antibody

STJ500483 St John's Laboratory 100 µg 571.2 EUR

Anti-CD80 antibody

STJ16100188 St John's Laboratory 100 µg 483.6 EUR

Anti-CD80 antibody

STJ16100189 St John's Laboratory 100 µg 628.8 EUR

Anti-CD80 antibody

STJ16101125 St John's Laboratory 100 µg 424.8 EUR

Anti-CD80 antibody

STJ170002 St John's Laboratory 100 µg 409.2 EUR
Description: The CD80 antigen (B7, BB1) recognizes a 60 kDa transmembrane glycoprotein, member of the immunoglobulin family. This molecule shares with CD86 the capability to be the ligand for two structurally similar molecules expressed on T lymphocytes, CD28 and CD152 (CTLA-4). CD80 antigen is expressed on in vitro activated B lymphocytes. It is not expressed on the majority of resting B cells from peripheral blood but identifies a subpopulation of B cells that has been previously activated. The antigen is also expressed by HTLV-1 transformed T cells activated monocytes, and constitutively on dendritic cells. CD80 binding provides costimulatory signals for T cell activation.

Anti-CD80 antibody

STJ72065 St John's Laboratory 100 µg 430.8 EUR

CD80 Antibody [8G12]

RF16041-002mg ProSci 0.02 mg 229.7 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody [8G12]

RF16041-01mg ProSci 0.1 mg 594.26 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody [10A1]

RF16042-002mg ProSci 0.02 mg 229.7 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody [10A1]

RF16042-01mg ProSci 0.1 mg 594.26 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody [7A2]

RF16043-002mg ProSci 0.02 mg 229.7 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody [7A2]

RF16043-01mg ProSci 0.1 mg 594.26 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody [11D1]

RF16044-002mg ProSci 0.02 mg 229.7 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody [11D1]

RF16044-01mg ProSci 0.1 mg 594.26 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody [11C12]

RF16045-002mg ProSci 0.02 mg 229.7 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody [11C12]

RF16045-01mg ProSci 0.1 mg 594.26 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody [12D9]

RF16046-002mg ProSci 0.02 mg 229.7 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Antibody [12D9]

RF16046-01mg ProSci 0.1 mg 594.26 EUR
Description: CD80 Antibody: CD80, also known as B7-1, is a type I membrane protein that is a member of the immunoglobulin superfamily. Like the related protein CD86, this protein is expressed by antigen-presenting cells, and is the ligand for two proteins at the cell surface of T cells, CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Binding of this protein with CD28 antigen is a costimulatory signal for activation of the T-cell and induces T-cell proliferation and cytokine production. CTLA-4 binding negatively regulates T-cell activation and diminishes the immune response (1). Blocking the CTLA-4-CD80/CD86 interaction has been shown to enhance T-cell functions in acute lymphoblastomic leukemia (ALL), suggesting that this pathway may be an attractive target for future cancer immunotherapy (2).

CD80 Peptide

42-780P ProSci 0.1 mg 405.6 EUR
Description: (IN) CD80 peptide

CD80 siRNA

20-abx911077 Abbexa
  • 661.20 EUR
  • 878.40 EUR
  • 15 nmol
  • 30 nmol

CD80 siRNA

20-abx911078 Abbexa
  • 661.20 EUR
  • 878.40 EUR
  • 15 nmol
  • 30 nmol

CD80 Peptide

8679P ProSci 0.05 mg 197.7 EUR
Description: CD80 Peptide

anti-CD80

YF-PA10781 Abfrontier 50 ug 435.6 EUR
Description: Mouse polyclonal to CD80

anti-CD80

YF-PA10782 Abfrontier 100 ul 483.6 EUR
Description: Rabbit polyclonal to CD80

anti-CD80

YF-PA10784 Abfrontier 100 ug 483.6 EUR
Description: Rabbit polyclonal to CD80

CD80 antibody (Spectral Red)

61R-CD80bMSSP Fitzgerald 100 ug 535.2 EUR
Description: Rat monoclonal CD80 antibody (Spectral Red)

CD80 antibody (Azide Free)

10R-CD80bMP Fitzgerald 500 ug 548.4 EUR
Description: Rat monoclonal CD80 antibody (Azide Free)

Anti-CD80 Antibody BIOTIN

STJ500484 St John's Laboratory 100 µg 703.2 EUR

Anti-CD80 Antibody FITC

STJ500485 St John's Laboratory 100 µg 703.2 EUR

Recombinant Rabbit B7-1/CD80 (C-6His)

CP57-10ug Novoprotein 10ug 120 EUR
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Rabbit B7-1/CD80 (C-6His)

CP57-1mg Novoprotein 1mg 1155.6 EUR
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Rabbit B7-1/CD80 (C-6His)

CP57-500ug Novoprotein 500ug 850.8 EUR
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Rabbit B7-1/CD80 (C-6His)

CP57-50ug Novoprotein 50ug 169.2 EUR
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Rabbit Anti-Human CD80 monoclonal antibody, clone KG21-5

CABT-L900 Creative Diagnostics 100 ul 932.4 EUR

Human T-lymphocyte activation antigen CD80 (CD80)

1-CSB-MP004959HU1 Cusabio
  • 327.60 EUR
  • 1052.40 EUR
  • 453.60 EUR
  • 786.00 EUR
  • 100ug
  • 1MG
  • 200ug
  • 500ug
Description: Recombinant Human T-lymphocyte activation antigen CD80(CD80),partial expressed in Mammalian cell

Human T-lymphocyte activation antigen CD80 (CD80)

1-CSB-CF1054HU Cusabio
  • 1512.00 EUR
  • 642.00 EUR
  • 948.00 EUR
  • 1MG
  • 200ug
  • 500ug
Description: Recombinant Human T-lymphocyte activation antigen CD80(CD80) expressed in in vitro E.coli expression system

Monoclonal CD80 Antibody, Clone: 2A2

APG02506G Leading Biology 0.1ml 580.8 EUR
Description: A Monoclonal antibody against Human CD80. The antibodies are raised in Mouse and are from clone 2A2. This antibody is applicable in IHC, ICC, E

CD80 Recombinant Protein

90-399 ProSci 100 ug 651.3 EUR
Description: CD80 (B7-1) and CD86 (B7-2) together with their receptors CD28 and CTLA-4 constitute one of the dominant costimulatory pathways that regulate T cell and B cell responses. Although both CTLA-4 and CD28 can bind to the same ligands, CTLA-4 binds to B7-1 and B7-2 with a 20-100 fold higher affinity than CD28 and is involved in the down-regulation of the immune response. B7-1 is expressed on activated B cells, activated T cells and macrophages. B7-2 is constitutively expressed on interdigitating dendritic cells, Langerhans cells, peripheral blood dendritic cells, memory B cells, and germinal center B cells. Additionally, B7-2 is expressed at low levels on monocytes and can be up-regulated through interferon-gamma. B7-1 and B7-2 are both members of the immunoglobulin superfamily. It has been observed that both human and mouse B7-1 and B7-2 can bind to either human or mouse CD28 and CTLA-4, suggesting that there are conserved amino acids which form the B7-1/B7-2/CD28/CTLA-4 critical binding sites.

CD80 Recombinant Protein

90-400 ProSci 100 ug 651.3 EUR
Description: CD80 (B7-1) and CD86 (B7-2) together with their receptors CD28 and CTLA-4 constitute one of the dominant costimulatory pathways that regulate T cell and B cell responses. Although both CTLA-4 and CD28 can bind to the same ligands, CTLA-4 binds to B7-1 and B7-2 with a 20-100 fold higher affinity than CD28 and is involved in the down-regulation of the immune response. B7-1 is expressed on activated B cells, activated T cells and macrophages. B7-2 is constitutively expressed on interdigitating dendritic cells, Langerhans cells, peripheral blood dendritic cells, memory B cells, and germinal center B cells. Additionally, B7-2 is expressed at low levels on monocytes and can be up-regulated through interferon-gamma. B7-1 and B7-2 are both members of the immunoglobulin superfamily. It has been observed that both human and mouse B7-1 and B7-2 can bind to either human or mouse CD28 and CTLA-4, suggesting that there are conserved amino acids which form the B7-1/B7-2/CD28/CTLA-4 critical binding sites.

CD80 Recombinant Protein

90-401 ProSci 100 ug 651.3 EUR
Description: CD80 (B7-1) and CD86 (B7-2) together with their receptors CD28 and CTLA-4 constitute one of the dominant costimulatory pathways that regulate T cell and B cell responses. Although both CTLA-4 and CD28 can bind to the same ligands, CTLA-4 binds to B7-1 and B7-2 with a 20-100 fold higher affinity than CD28 and is involved in the down-regulation of the immune response. B7-1 is expressed on activated B cells, activated T cells, and macrophages. B7-2 is constitutively expressed on interdigitating dendritic cells, Langerhans cells, peripheral blood dendritic cells, memory B cells and germinal center B cells. Additionally, B7-2 is expressed at low levels on monocytes and can be up-regulated through interferon-gamma. B7-1 and B7-2 are both members of the immunoglobulin superfamily. It has been observed that both human and mouse B7-1 and B7-2 can bind to either human or mouse CD28 and CTLA-4, suggesting that there are conserved amino acids which form the B7-1/B7-2/CD28/CTLA-4 critical binding sites.

CD80 Recombinant Protein

96-044 ProSci 0.1 mg 619.8 EUR
Description: B7-1 and B7-2, together with their receptors CD28 and CTLA­4, constitute one of the dominant co-stimulatory pathways that regulate T­ and B­cell responses. Although both CTLA­4 and CD28 can bind to the same ligands, CTLA­4 binds to B7­1 and B7­2 with a 20 ­ 100 fold higher affinity than CD28 and is involved in the down­regulation of the immune response.B-lymphocyte activation antigen B7-1 (referred to as B7) also known as cluster of Differentiation 80 (CD80), is a member of cell surface immunoglobulin superfamily and is expressed on activated B cells, activated T cells, macrophages and dendritic cells. It is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD80 works in tandem with CD86 to prime T cells. CD80 plays a role in induction of innate immune responses by activating NF-κB-signaling pathway in macrophages. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.

CD80 Recombinant Protein

96-045 ProSci 0.1 mg 619.8 EUR
Description: B7­1 and B7­2, together with their receptors CD28 and CTLA­4, constitute one of the dominant co-stimulatory pathways that regulate T­ and B­cell responses. Although both CTLA­4 and CD28 can bind to the same ligands, CTLA­4 binds to B7­1 and B7­2 with a 20 ­ 100 fold higher affinity than CD28 and is involved in the down­regulation of the immune response.B-lymphocyte activation antigen B7-1 (referred to as B7) also known as cluster of Differentiation 80 (CD80), is a member of cell surface immunoglobulin superfamily and is expressed on activated B cells, activated T cells, macrophages and dendritic cells. It is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD80 works in tandem with CD86 to prime T cells. CD80 plays a role in induction of innate immune responses by activating NF-κB-signaling pathway in macrophages. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.

CD80 Recombinant Protein

96-085 ProSci 0.1 mg 619.8 EUR
Description: B7-1 and B7-2, together with their receptors CD28 and CTLA­4, constitute one of the dominant co-stimulatory pathways that regulate T­ and B­cell responses. Although both CTLA­4 and CD28 can bind to the same ligands, CTLA­4 binds to B7­1 and B7­2 with a 20 ­ 100 fold higher affinity than CD28 and is involved in the down­regulation of the immune response.B-lymphocyte activation antigen B7-1 (referred to as B7) also known as cluster of Differentiation 80 (CD80), is a member of cell surface immunoglobulin superfamily and is expressed on activated B cells, activated T cells, macrophages and dendritic cells. It is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD80 works in tandem with CD86 to prime T cells. CD80 plays a role in induction of innate immune responses by activating NF-κB-signaling pathway in macrophages. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.

CD80 Blocking Peptide

DF7682-BP Affbiotech 1mg 234 EUR

B7-1/CD80

E21-K61 EnoGene 10ug 411.6 EUR

anti-CD80 (2A2)

LF-MA30281 Abfrontier 100 ul 583.2 EUR
Description: Mouse Monoclonal to CD80

Anti-CD80 (1G1)

YF-MA12322 Abfrontier 100 ug 435.6 EUR
Description: Mouse monoclonal to CD80

Anti-CD80 (3E10)

YF-MA12323 Abfrontier 200 ul 435.6 EUR
Description: Mouse monoclonal to CD80

Anti-CD80 (4A4)

YF-MA12324 Abfrontier 200 ul 435.6 EUR
Description: Mouse monoclonal to CD80

Anti-CD80 (3D7)

YF-MA12325 Abfrontier 100 ug 435.6 EUR
Description: Mouse monoclonal to CD80

Mouse T-lymphocyte activation antigen CD80(CD80) ELISA kit

CSB-EL004959MO-24T Cusabio 1 plate of 24 wells 198 EUR
Description: Quantitative sandwich ELISA kit for measuring Mouse T-lymphocyte activation antigen CD80 (CD80) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Mouse T-lymphocyte activation antigen CD80(CD80) ELISA kit

1-CSB-EL004959MO Cusabio
  • 843.60 EUR
  • 5811.60 EUR
  • 3084.00 EUR
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitative sandwich ELISA kit for measuring Mouse T-lymphocyte activation antigen CD80(CD80) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human CD80/ T-lymphocyte activation antigen CD80 ELISA Kit

E0441Hu Sunlong 1 Kit 675.6 EUR

Human CD80(T-lymphocyte activation antigen CD80) ELISA Kit

EH0088 FN Test 96T 681.12 EUR
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 46.9pg/ml

Human T- lymphocyte activation antigen CD80, CD80 ELISA KIT

ELI-06511h Lifescience Market 96 Tests 988.8 EUR

Mouse T- lymphocyte activation antigen CD80, Cd80 ELISA KIT

ELI-06512m Lifescience Market 96 Tests 1038 EUR

Cluster of differentiation 80 (CD80) Antibody

20-abx111494 Abbexa
  • 878.40 EUR
  • 477.60 EUR
  • 150 ul
  • 50 ul

Cluster of differentiation 80 (CD80) Antibody

20-abx323191 Abbexa
  • 376.80 EUR
  • 292.80 EUR
  • 100 ug
  • 50 ug

Cluster of differentiation 80 (CD80) Antibody

20-abx339272 Abbexa
  • 493.20 EUR
  • 360.00 EUR
  • 100 ul
  • 50 ul

Cluster of differentiation 80 (CD80) Antibody

20-abx210922 Abbexa
  • 493.20 EUR
  • 360.00 EUR
  • 100 ul
  • 50 ul

CD80 (B7-1) (C80/1608) Antibody

BNC041608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF405S conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC041608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF405S conjugate, Concentration: 0.1mg/mL

Mouse Anti-Human CD80 mAbConjugated Antibody

CCM015 SAB 100ul 476.4 EUR

CD80 (B7-1) (C80/1608) Antibody

BNCAP1608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNCAP1608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNCH1608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNCH1608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNCP1608-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),PerCP conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNCR1608-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),RPE conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC941608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF594 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC941608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF594 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNCA1608-250 Biotium 250uL 459.6 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),APC conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC811608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF680R conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC811608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF680R conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNUB1608-100 Biotium 100uL 250.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608), Concentration: 0.2mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNUB1608-500 Biotium 500uL 549.6 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608), Concentration: 0.2mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC881608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF488A conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC881608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF488A conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNCB1608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),Biotin conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNCB1608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),Biotin conjugate, Concentration: 0.1mg/mL

Rat Anti Mouse Cd80 Monoclonal Antibody

CABT-46717RM Creative Diagnostics 0.1 mg 546 EUR

CD80 (B7-1) (C80/1608) Antibody

BNC611608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF660R conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC611608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF660R conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC681608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF568 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC681608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF568 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC431608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF543 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC431608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF543 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC471608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF647 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC471608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF647 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC401608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF640R conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC401608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF640R conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC551608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF555 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC551608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF555 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC801608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF680 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC801608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF680 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC051608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF405M conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC051608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF405M conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC701608-100 Biotium 100uL 238.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF770 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNC701608-500 Biotium 500uL 652.8 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608),CF770 conjugate, Concentration: 0.1mg/mL

CD80 (B7-1) (C80/1608) Antibody

BNUM1608-50 Biotium 50uL 474 EUR
Description: Primary antibody against CD80 (B7-1) (C80/1608), 1mg/mL

Cd80 ELISA Kit| Mouse T-lymphocyte activation antigen CD80 ELIS

EF014437 Lifescience Market 96 Tests 826.8 EUR

Mouse CD80 ELISA Kit

55R-1739 Fitzgerald 1 kit 748.8 EUR
Description: ELISA kit for detection of B71 in the research laboratory

 

CD80 Rabbit Polyclonal Antibody